Literature DB >> 29679383

Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials.

Alexandra M Hanretty1, Jason C Gallagher2.   

Abstract

Commonly prescribed durations of therapy for many, if not most, bacterial infections are not evidence-based. Misunderstandings by clinicians and patients alike influence perspectives on antibiotic use, including duration of therapy and its role in antibiotic resistance. To demonstrate that shorter durations of antibiotic therapy are as efficacious as longer durations for many infections, a systematic review was undertaken of English-language articles by using PubMed to identify articles for inclusion. Additionally, infection-specific guidelines were identified for review of recommendations. Search terms included specific infection types, randomized controlled trial (RCT), duration of therapy, treatment duration, short course, and long course. Only RCTs of single-agent antibiotic therapy for the treatment of bacterial infections in adults were included. Independent data extraction of articles was conducted by two authors by using predefined guidance for article inclusion. In total, 23 RCTs met our criteria for inclusion. All trials compared single-agent antibiotics for a short and long antibiotic course in six common infections: community-acquired pneumonia, ventilator-associated pneumonia, intraabdominal infections, skin and soft tissue infections, uncomplicated cystitis, and complicated cystitis or pyelonephritis. Clinicians can decrease net antibiotic use by recommending shorter courses where evidence supports them. Antimicrobial stewardship programs that systematically address treatment duration may significantly affect institutional antibiotic use without negatively affecting patient care.
© 2018 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  antibiotics; antimicrobial stewardship; bacterial infections; duration of therapy

Mesh:

Substances:

Year:  2018        PMID: 29679383     DOI: 10.1002/phar.2118

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  22 in total

1.  Duration of antibiotic therapy in pyelonephritis: when shorter is better.

Authors:  Elisa Russo; Francesca Viazzi
Journal:  Intern Emerg Med       Date:  2020-07-14       Impact factor: 3.397

2.  Short-course Antibiotic Therapy-Replacing Constantine Units With "Shorter Is Better".

Authors:  Noah Wald-Dickler; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

3.  Short vs long-course antibiotic therapy in pyelonephritis: a comparison of systematic reviews and guidelines for the SIMI choosing wisely campaign.

Authors:  Luca Erba; Ludovico Furlan; Alice Monti; Elisa Marsala; Giulia Cernuschi; Monica Solbiati; Christian Bracco; Giulia Bandini; Monica Pecorino Meli; Giovanni Casazza; Nicola Montano; Rodolfo Sbrojavacca; Giorgio Costantino
Journal:  Intern Emerg Med       Date:  2020-06-21       Impact factor: 3.397

4.  Duration of Antibiotic Therapy: Shorter Is Better.

Authors:  Brad Spellberg; Louis B Rice
Journal:  Ann Intern Med       Date:  2019-07-09       Impact factor: 25.391

5.  Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.

Authors:  T D Trinh; S C J Jorgensen; E J Zasowski; K C Claeys; A M Lagnf; S J Estrada; D J Delaportes; V Huang; K P Klinker; K S Kaye; S L Davis; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 6.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

7.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

Review 8.  Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Isabela R Marques; Izabela P Calvi; Sara A Cruz; Luana M F Sanchez; Isis F Baroni; Christi Oommen; Eduardo M H Padrao; Paula C Mari
Journal:  Eur J Pediatr       Date:  2022-09-06       Impact factor: 3.860

9.  Benefits of set length antibiotic treatment for pulmonary exacerbations.

Authors:  Christopher H Goss; Ranjani Somayaji; Patrick A Flume
Journal:  Lancet Respir Med       Date:  2018-06-27       Impact factor: 30.700

10.  Combined influence of practice guidelines and prospective audit and feedback stewardship on antimicrobial treatment of community-acquired pneumonia and empyema in children: 2012 to 2016.

Authors:  Nicole M A Le Saux; Jennifer Bowes; Isabelle Viel-Thériault; Nisha Thampi; Julie Blackburn; Melanie Buba; Mary-Ann Harrison; Nick Barrowman
Journal:  Paediatr Child Health       Date:  2020-06-30       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.